All patients had typical features of clEDS: joint hypermobility, easy bruising, and skin hyperextensibility without atrophic scars
It has since been found in saliva and urine as well
Common Conditions: Rotator cuff strain, labral tears, bicep tendinitis, shoulder impingement Typical BPC-157 Approach: 0.25 to 0.5 mg daily via subcutaneous injection Injection Proximity: 1 to 2 inches from affected structure Expected Timeline: 4 to 8 weeks for significant improvement Complementary Work: Physical therapy, rotator cuff strengthening, mobility work Knee Injuries Knees absorb tremendous forces in martial arts
My protocol during this period: Retatrutide: 2mg weekly subcutaneous injection (ramped to 4mg by week 10) GHK-Cu: 1mg daily subcutaneous, rotated injection sites Cycle length: 12 weeks on, 4 weeks off Training: 4 days resistance training per week, 8,000 to 10,000 steps daily Protein intake: 130g daily minimum I sourced both from Red Fox Peptides
